Intracellular trafficking of Fas ligand in cytotoxic T lymphocytes
Intracellular trafficking of Fas ligand in cytotoxic T lymphocytes
批准号:
435798-2013
负责人:
Ostergaard, Hanne
金额:
$2.19万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2013
资助国家:
加拿大
项目状态:
已结题
起止时间:
2013-01-01 至 2014-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
There is a type of white blood cell called a T cell that specializes in killing cancer cells or cells that have become infected with viruses or bacteria. This specialized T cell is called a cytotoxic T lymphocyte or CTL. CTL have two very effective ways of killing cells. The first way is the release of a number of proteins from the killer cell, called cytolytic molecules, which are able to enter the defective cell and kill it. The other mechanism is the expression of a molecule on the cell surface called Fas ligand (FasL) that triggers cells that have a molecule called Fas on the cell surface to commit suicide. Since essentially all cells in the body have Fas on the cell surface, the CTL must tightly control the amount of FasL on the cell surface so that they do not go around and trigger all of the cells in the body to commit suicide. We have found that CTL control the amount of FasL on the cell surface by holding the FasL in vesicles, or bags, within the cell. When the CTL recognizes that a cell is abnormal in some way, it then quickly moves the FasL to the cell surface but only in the direction where the normal cell is bound, where it triggers suicide of the cell, and then the FasL rapidly disappears again from the cell surface. This is an effective way to kill only the infected cell while sparing the normal surrounding cells. This study is focused on trying to understand how the FasL is stored in these vesicles in the cell and what triggers it to move to the cell surface. We will use a sophisticated microscope to visualize the movement of FasL in CTL in real time when it encounters an abnormal cell. This will allow us to determine the conditions that cause the movement and deployment of the FasL to the cell surface. We will also gain insight into how cells can control the movement and directional localization of molecules.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
LEPROTL1在胶原蛋白从内质网输出过程中的机制研究
-
批准号:32100550
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:高经虎
-
依托单位:
PES-7/IQGAP在内吞循环运输中的调控作用及机制研究
-
批准号:32100552
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:张文娟
-
依托单位:
PI4KIIα调控CD36从高尔基体往质膜转运的机制
-
批准号:32100539
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:王娟
-
依托单位:
平面细胞极化蛋白Frizzled6在早期分泌转运途中运输的分子机制
-
批准号:32070699
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:郭玉松
-
依托单位:
膜融合介导蛋白SNARE复合体在解聚过程中的作用机制研究
-
批准号:32000485
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:黄轩
-
依托单位:
重要内质网塑形蛋白在疟原虫致病性方面的作用研究
-
批准号:32070701
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:王倩
-
依托单位:
新跨膜因子Angel Face调控质膜向自噬体膜转化的机理研究
-
批准号:92054109
-
项目类别:重大研究计划
-
资助金额:82.0万元
-
批准年份:2020
-
负责人:李周华
-
依托单位:
CHW-1/RhoU/RhoV作为潜在微丝稳态调控因子在循环运输中的功能研究
-
批准号:32070703
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:林珑
-
依托单位:
自发性钙振荡调控星形胶质细胞突起极性生长的功能和分子机制研究
-
批准号:32070700
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:洪智
-
依托单位:
微丝亲和蛋白RTKN-1/Rhotekin在内吞循环运输中的功能机制研究
-
批准号:32000489
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:严雁玲
-
依托单位: